Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
Sodium Pertechnetate Tc-99m is a radiopharmaceutical diagnostic agent used for nuclear medicine imaging procedures. It is administered via injection or oral routes to visualize various organ systems and detect abnormalities. The drug functions as a tracer that allows clinicians to obtain functional and anatomical information about targeted tissues.
Product approaching loss of exclusivity with moderate competitive pressure (30/100); expect transition planning and team consolidation as lifecycle enters mature phase.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Sodium Pertechnetate Tc-99m offers stability in a mature diagnostic product but limited growth opportunities as LOE approaches. Career value lies in mastery of radiopharmaceutical manufacturing, regulatory compliance, and operational excellence rather than commercial expansion or innovation.
Worked on SODIUM PERTECHNETATE TC 99M at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.